Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington's disease knock-in mice

Dazhang Bai1,2, Fuyu Deng1,3, Qingqing Jia1

  • 1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Key Laboratory of non-human Primate Research, Guangdong-Hongkong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, Guangdong, China.

Aging Cell
|August 26, 2024
PubMed

Insights

Cytoplasmic TDP-43 accumulation in Huntington's disease (HD) models exacerbates motor deficits. This mislocalized TDP-43 binds Htt pre-mRNA, promoting toxic protein production and contributing to HD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) results from CAG repeat expansion in the HTT gene, leading to toxic huntingtin protein fragments.
  • TDP-43 is typically nuclear but mislocalizes to the cytoplasm in pathological conditions.

Purpose of the Study:

  • To investigate the role of cytoplasmic TDP-43 in Huntington's disease pathogenesis using HD knock-in mouse models.
  • To determine if TDP-43 mislocalization contributes to disease progression and aberrant protein generation.

Main Methods:

  • Utilized HD knock-in mice expressing a cytoplasmic TDP-43 variant lacking a nuclear localization signal.
  • Analyzed TDP-43 localization and its impact on motor and gait behavior in mouse models.
  • Investigated TDP-43 binding to Htt pre-mRNA and its effect on exon1 Htt generation.

Main Results:

  • Increased cytoplasmic TDP-43 was observed in the brains of HD mice.
  • Cytoplasmic TDP-43 mislocalization correlated with worsened motor and gait behavior.
  • Cytoplasmic TDP-43 binds to Htt pre-mRNA intron1, promoting the ribosomal transport and aberrant generation of exon1 Htt.

Conclusions:

  • Cytoplasmic TDP-43 is a key contributor to Huntington's disease pathogenesis.
  • TDP-43's aberrant transport of Htt pre-mRNA to ribosomes generates toxic protein products, driving disease progression.